Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Amazon
AMZN
|
+$767M |
| 2 |
Applied Materials
AMAT
|
+$278M |
| 3 |
Kenvue
KVUE
|
+$223M |
| 4 |
Salesforce
CRM
|
+$217M |
| 5 |
S&P Global
SPGI
|
+$214M |
Top Sells
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.25B |
| 2 |
Advanced Micro Devices
AMD
|
+$576M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$446M |
| 4 |
Microsoft
MSFT
|
+$341M |
| 5 |
Chubb
CB
|
+$329M |
Sector Composition
| 1 | Technology | 27.91% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 11.26% |
| 4 | Consumer Discretionary | 11.01% |
| 5 | Industrials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Leonardo DRS
DRS
$11.2B
| $3.46M | ﹤0.01% |
199,701
+135,636
| +212% | +$2.35M |
|
2052
Twist Bioscience
TWST
$1.53B
| $3.46M | ﹤0.01% |
169,161
+20,320
| +14% | +$416K |
|
2053
Manitowoc
MTW
$362M
| $3.45M | ﹤0.01% |
182,982
-56,000
| -23% | -$1.05M |
|
2054
Ooma
OOMA
$345M
| $3.44M | ﹤0.01% |
229,488
+37,180
| +19% | +$557K |
|
2055
Astrana Health
ASTH
$1.38B
| $3.43M | ﹤0.01% |
108,570
-13,374
| -11% | -$423K |
|
2056
TPG
TPG
$9.05B
| $3.43M | ﹤0.01% |
+117,109
| New | +$3.43M |
|
2057
Cantaloupe
CTLP
$792M
| $3.42M | ﹤0.01% |
429,513
-128,940
| -23% | -$1.03M |
|
|
PMT
2058
PennyMac Mortgage Investment
PMT
$1.07B
| $3.4M | ﹤0.01% |
252,518
-23,432
| -8% | -$316K |
|
2059
Liquidity Services
LQDT
$849M
| $3.39M | ﹤0.01% |
205,532
-18,646
| -8% | -$308K |
|
2060
Liberty Global Class A
LBTYA
$4.05B
| $3.39M | ﹤0.01% |
200,979
-218,001
| -52% | -$3.68M |
|
|
IBTX
2061
DELISTED
Independent Bank Group, Inc.
IBTX
| $3.39M | ﹤0.01% |
98,128
| – | – |
|
2062
Procept Biorobotics
PRCT
$2.07B
| $3.38M | ﹤0.01% |
95,521
+24,275
| +34% | +$858K |
|
2063
Syndax Pharmaceuticals
SNDX
$1.34B
| $3.37M | ﹤0.01% |
160,947
+9,710
| +6% | +$203K |
|
2064
Stock Yards Bancorp
SYBT
$2.27B
| $3.36M | ﹤0.01% |
73,972
+795
| +1% | +$36.1K |
|
2065
Independent Bank Corp
IBCP
$657M
| $3.35M | ﹤0.01% |
197,270
-749
| -0.4% | -$12.7K |
|
2066
Acco Brands
ACCO
$361M
| $3.34M | ﹤0.01% |
640,654
-81,675
| -11% | -$426K |
|
|
TWO
2067
Two Harbors Investment
TWO
$1.05B
| $3.33M | ﹤0.01% |
239,964
+3,901
| +2% | +$54.1K |
|
2068
Pulmonx
LUNG
$69.3M
| $3.33M | ﹤0.01% |
253,949
+17,619
| +7% | +$231K |
|
2069
3D Systems Corporation
DDD
$286M
| $3.32M | ﹤0.01% |
334,474
-3,120
| -0.9% | -$31K |
|
2070
Zentalis Pharmaceuticals
ZNTL
$107M
| $3.31M | ﹤0.01% |
117,396
+2,885
| +3% | +$81.4K |
|
|
ATRI
2071
DELISTED
Atrion Corp
ATRI
| $3.31M | ﹤0.01% |
5,850
+192
| +3% | +$109K |
|
|
VERV
2072
DELISTED
Verve Therapeutics
VERV
| $3.3M | ﹤0.01% |
175,904
+15,180
| +9% | +$285K |
|
2073
Levi Strauss
LEVI
$8.67B
| $3.28M | ﹤0.01% |
227,381
+47,023
| +26% | +$679K |
|
2074
Avanos Medical
AVNS
$567M
| $3.28M | ﹤0.01% |
128,291
-49,480
| -28% | -$1.26M |
|
2075
MINISO
MNSO
$7.56B
| $3.28M | ﹤0.01% |
192,900
+2,000
| +1% | +$34K |
|